bf/NASDAQ:ANNX_icon.png

COM:ANNEXONBIO

Annexon, Inc.

  • Stock

USD

Last Close

5.17

22/11 21:00

Market Cap

531.29M

Beta: -

Volume Today

1.16M

Avg: -

Description

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product can...Show More

peer of